Unscrupulous Weight Loss Trends: MMA Exposes Shady Practices in the Beauty Industry
Are beauty clinics cutting corners with dangerous diabetes drugs?
The Malaysian Medical Association (MMA) has issued a stark warning about a concerning trend in the beauty industry. Some doctors are allegedly leasing their credentials to aesthetic operators, allowing the sale of powerful diabetes medications for weight loss without proper medical supervision.
And here's where it gets controversial: these medications, like semaglutide and tirzepatide (known as Ozempic and Mounjaro), are being marketed as quick-fix cosmetic solutions, but they're not meant to be used this way. Dr. Thirunavukarasu Rajoo, MMA president, emphasizes that these drugs were developed for specific clinical conditions, including diabetes and obesity, and require structured medical supervision.
But what's even more alarming is the potential harm to patients. Dr. Rajoo warns that prescribing these medications without thorough medical assessments and follow-ups can lead to severe side effects, including gastrointestinal issues and dehydration, and even more serious complications.
The MMA is taking a strong stance, stating that doctors remain legally and professionally accountable, even if they are not physically present at the clinics. They urge the public to be cautious and ensure their doctors are registered and provide proper assessments and counseling.
This story raises important questions about the ethics of the beauty industry and the potential risks patients face when seeking cosmetic procedures. Are these practices putting profits before patient safety? Share your thoughts in the comments below.
